Tectonic Therapeutic | AVRO - Fremdkapital





Fremdkapital Veränderung Datum
Akebia Therapeutics USD 48.25M 609K 2025-12
Alnylam Pharmaceuticals USD 2.48B 1.44B 2025-12
Celltrion KRW 63.29B 4.01B 2025-09
Cspc Pharmaceutical CNY 180.69M 21.94M 2025-12
Deva Holding AS TRY 559.97M 44.39M 2023-09
Dianthus Therapeutics USD 0 0 2024-12
Divis Laboratories Ltd INR 20M 0 2025-03
Gilead Sciences USD 22.14B 5M 2025-09
Ionis Pharmaceuticals USD 1.9B 1.87B 2025-12
Kangmei Pharma CNY 78.45M 5.8M 2025-09
Karyopharm Therapeutics USD 278.22M 278.22M 2025-12
Knight Therapeutics CAD 57.78M 26.92M 2025-12
Laboratorios Farma EUR 80.5M 28.26M 2024-12
MacroGenics USD 70M 256K 2025-12
Malin Corporation EUR 0 0 2024-12
Medical Developments International AUD 1.5M 167K 2025-12
Organigram Holdings CAD 62.52M 13.88M 2025-12
Ovoca Bio EUR 0 0 2021-06
Pfizer USD 57.41B 93M 2025-09
Pharma Mar EUR 36.68M 1.07M 2025-12
Qiagen NV USD 1.65B 15.23M 2025-12
Roche Holding CHF 27.43B 966M 2025-12
Sangamo BioSciences USD 0 0 2022-06
Sanofi EUR 15.72B 2.45B 2025-12
Sarepta Therapeutics USD 828.97M 206.17M 2025-12
Sartorius EUR 3.41B 682.5M 2025-09
Sino Biopharmaceutical CNY 3.08B 1B 2025-06
Takeda JPY 4.27T 81.29B 2025-12
Tilray USD 268.59M 3.82M 2025-09
Zealand Pharma A/S 383.14M 727K 2025-12
Zz Pientze Pharmaceu CNY 186.56M 9.75M 2025-09